Skip to main content

Table 1

From: Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer

Immune Cell Subset

Baseline

Post GC

Post GC + Ipi

Wilcoxon signed-rank text (p value)

    

Post-GC versus Baseline

Post-GC + Ipi versus Post GC

Post-GC + Ipi verus Baseline

%CD3CD4

8.3 (5.5-13.10)

9.7 (5.1-16.4)

15.8 (9.4-27.0)

0.13

0.008

0.001

%CD3CD8

4.4 (2.6-6.7)

4.8 (3.1-7.6)

7.3 (4.2-13.5)

0.9

0.06

0.01

% Tregs

6.5 (4.1-7.4)

6.2 (5.2-8.8)

6.2 (4.4-8.0)

0.6

0.4

0.8

% Granulcytic MDSC

0.05 (0.01-.1)

0.04 (0.01-0.1)

0.04 (0.01-0.08)

0.7

0.8

0.4

% Monocytic MDSC

0.01 (0.007-0.03)

0.01 (0.004-0.02)

0.02 (0.007-0.03)

0.3

0.09

0.9